Home
Conditions
Smallpox

Clinical trial condition

Smallpox

Explore clinical trials studying Smallpox. Study availability and eligibility vary by location and protocol.

65 public trials 2 recruiting studies

Refine in advanced search Browse all conditions

Smallpox trial results

Recruiting

A Randomized Clinical Trial Investigating the Safety, Reactogenicity, and Immunogenicity After Immunization With an mRNA-based Mpox Vaccine Candidate in Africa

NCT07379580

Conditions: Animal Diseases, DNA Virus Infections, Infections, +8 more
Locations: University of Kinshasa UNIKIN Kinshasa, Democratic Republic of the Congo

Institute National de Recherche Biomedicale Kinshasa, Democratic Republic of the Congo

TASK Applied Science Cape Town, South Africa

TREAD Research Pty Ltd Cape Town, South Africa

View Trial Details

Recruiting

Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of BSY001 After Single/Multiple Doses.

NCT07377175

Conditions: Animal Diseases, Cowpox, DNA Virus Infections, +9 more
Locations: Shulan (Hangzhou) Hospital Hangzhou, China

View Trial Details

Not yet recruiting

Assessment of Myocarditis After Replication-Deficient Smallpox Immunization

NCT05513313

Conditions: DNA Virus Infections, Infections, Myopericarditis, +4 more
Locations: Not specified

View Trial Details

Enrolling by invitation

VA-005 Clinical Outcomes of VIGIV Treatment of Smallpox Vaccination Complications or Vaccinia Infection

NCT01374984

Conditions: Complication of Smallpox Vaccination, DNA Virus Infections, Infections, +3 more
Locations: Not specified

View Trial Details

Active, not recruiting

Study to Assess the Safety and Immunogenicity of TPOXX® When Administered Orally for 28 Days With JYNNEOS

NCT04957485

Conditions: DNA Virus Infections, Infections, Poxviridae Infections, +2 more
Locations: Meridian Clinical Research Omaha, Nebraska, United States

Aventiv Research Inc Columbus, Ohio, United States

View Trial Details

Active, not recruiting

Phase 3 Infant Safety & Immunogenicity Trial of MVA-BN® in DRC

NCT06844487

Conditions: Animal Diseases, Children, DNA Virus Infections, +12 more
Locations: Boende Hôpital Général de Référence, Boende Boende, La Tshuapa, Democratic Republic of the Congo

View Trial Details

Active, not recruiting

Phase 3 Maternal Safety & Immunogenicity Trial of MVA-BN® in DRC

NCT06844500

Conditions: Animal Diseases, DNA Virus Infections, Immunogenicity, +14 more
Locations: Boende Hôpital Général de Référence Boende, Province de La Tshuapa, Democratic Republic of the Congo

View Trial Details

Completed

Safety, Tolerability, Pharmacokinetics (PK) of the Anti-Orthopox Drug, ST-246

NCT00907803

Conditions: DNA Virus Infections, Infections, Orthopoxviral Disease, +3 more
Locations: Apex Research Institute Santa Ana, California, United States

Orlando Clinical Research Center Orlando, Florida, United States

Hawaii Clinical Research Center Honolulu, Hawaii, United States

View Trial Details

Completed

Safety, Tolerability and Pharmacokinetics of TPOXX When Administered Orally for 28 Days

NCT04971109

Conditions: DNA Virus Infections, Infections, Poxviridae Infections, +2 more
Locations: Clinical Pharmacology of Miami, LLC Miami, Florida, United States

Advanced Pharma Miami, Florida, United States

Orlando Clinical Research Center Orlando, Florida, United States

Meridian Clinical Research Omaha, Nebraska, United States

View Trial Details

Completed

Safety, Tolerability and PK of TPOXX in Adults Weighing More Than 120 KG

NCT04392739

Conditions: DNA Virus Infections, Infections, Poxviridae Infections, +2 more
Locations: PPD Phase I Clinic Austin, Texas, United States

View Trial Details

Smallpox

Smallpox trial results

Related conditions